Alzheimer’s pTau217 Blood Test in Lymington – £479
BOOK YOUR TEST AND BLOOD DRAW HERE
Concerned about changes in memory or cognitive function?
The LucentAD pTau217™ Alzheimer’s Blood Test is an advanced, non-invasive blood test designed to support the clinical assessment of Alzheimer’s disease by measuring p-Tau217 – an important blood biomarker strongly associated with Alzheimer’s pathology.
Available at Rènü Dermatology in Lymington for £479 including your professional in-clinic venous blood draw.
LucentAD pTau217™ Alzheimer’s Blood Test – £479
✓ Measures the p-Tau217 Alzheimer’s biomarker
✓ Designed to support early assessment of Alzheimer’s disease
✓ Simple non-invasive blood test
✓ No lumbar puncture required
✓ No PET scan required for the blood test itself
✓ Professional venous blood draw included
✓ Specialist laboratory analysis
✓ Results within approximately 15 working days
✓ Suitable for adults aged 18+
What Is the LucentAD pTau217™ Alzheimer’s Blood Test?
LucentAD pTau217™ is a specialist blood test developed to provide additional information when Alzheimer’s disease is being considered as a possible cause of memory or cognitive symptoms.
The test measures phosphorylated tau 217 (p-Tau217), a biomarker strongly associated with the brain changes seen in Alzheimer’s disease.
Rather than requiring an invasive procedure, only a venous blood sample is needed.
What Is p-Tau217?
Tau is a protein naturally found within the brain.
Changes involving tau proteins are associated with Alzheimer’s disease. p-Tau217 is a specific form of phosphorylated tau that has emerged as an important blood biomarker when assessing Alzheimer’s pathology.
Measuring p-Tau217 can provide healthcare professionals with additional information about whether Alzheimer’s-related pathology is likely to be present.
Who Might Consider an Alzheimer’s Blood Test?
This specialist test may be appropriate for people who:
- Are experiencing memory concerns
- Have noticed changes in cognitive function
- Are undergoing investigation for possible dementia
- Are waiting for a specialist memory or dementia assessment
- Want additional information to discuss with their GP or specialist
- Are looking for a non-invasive blood-based assessment
- Have been advised by a healthcare professional to investigate Alzheimer’s biomarkers
Possible Changes That May Need Investigation
Memory and cognitive changes can occur for many reasons and do not automatically mean that someone has Alzheimer’s disease.
Changes worth discussing with a healthcare professional can include:
- Increasing forgetfulness
- Frequently repeating questions or conversations
- Difficulty remembering recent events
- Problems finding familiar words
- Difficulty concentrating
- Confusion about dates or places
- Difficulty completing familiar tasks
- Changes in judgement or decision-making
- Noticeable cognitive changes identified by family or friends
These symptoms can have numerous causes. A proper clinical assessment is important rather than assuming they are caused by Alzheimer’s disease.
Why Test p-Tau217?
p-Tau217 is considered one of the most specific blood biomarkers currently associated with Alzheimer’s disease pathology.
Elevated levels can provide evidence that Alzheimer’s-related biological changes may be present and can help guide conversations about whether further specialist assessment is appropriate.
A Simple Venous Blood Test
One of the major advantages of blood-based Alzheimer’s biomarkers is that testing requires only a standard venous blood sample.
Your sample is professionally collected from your arm at Rènü Dermatology before being sent to the specialist laboratory for p-Tau217 analysis.
Alternative to More Invasive Initial Testing
Traditional specialist investigation of suspected Alzheimer’s disease can involve procedures such as lumbar puncture to analyse cerebrospinal fluid or specialist brain imaging such as PET scans.
The LucentAD pTau217™ test provides a much simpler blood-based assessment that can contribute useful information to the wider clinical picture.
However, having this blood test does not mean that other investigations will never be required. Your doctor or specialist may still recommend additional assessment depending on your symptoms and result.
Can This Blood Test Diagnose Alzheimer’s Disease?
No. The LucentAD pTau217™ blood test should not be used on its own to diagnose Alzheimer’s disease.
The test is designed to support clinical assessment by providing information about a biomarker associated with Alzheimer’s pathology.
Your result should always be interpreted by an appropriately qualified healthcare professional alongside your symptoms, medical history, cognitive assessment and any other investigations considered necessary.
What Does “Clinically Meaningful in 70% of Patients” Mean?
The LucentAD pTau217™ test is designed to provide a clinically useful result that can help support whether Alzheimer’s pathology is more or less likely.
Goodbody reports that the test provides a clinically meaningful result in approximately 70% of patients.
This also means that some results may fall into an intermediate or less conclusive range, where further clinical investigation may still be necessary.
The test should therefore be viewed as part of a wider Alzheimer’s assessment rather than a standalone answer.
How Does the Alzheimer’s Blood Test Work?
-
Book your appointment
Arrange your LucentAD pTau217™ Alzheimer’s Blood Test at Rènü Dermatology in Lymington.
-
Attend your professional blood draw
A venous blood sample is professionally collected from your arm during your appointment.
-
Specialist laboratory analysis
Your sample is sent to the specialist laboratory where your p-Tau217 biomarker is analysed.
-
Receive your results
Results are normally available within approximately 15 working days after the laboratory receives your sample.
-
Discuss the result
Your result can be shared with your GP or specialist so it can be considered alongside your symptoms and wider clinical assessment.
Your Professional Blood Draw Is Included
There's no need to arrange phlebotomy separately.
The £479 price includes your LucentAD pTau217™ Alzheimer’s Blood Test AND professional venous blood collection at Rènü Dermatology in Lymington.
Understanding Your Result
The test provides information about Alzheimer’s pathology at the time your blood sample is taken.
Your result can help support a healthcare professional in determining whether Alzheimer’s-related pathology appears more or less likely.
It should not be interpreted in isolation and should not be used to self-diagnose Alzheimer’s disease.
If you're experiencing memory or cognitive symptoms, your result should be discussed with your GP, memory clinic or an appropriately qualified specialist.
What Happens If My Result Suggests Alzheimer’s Pathology?
An abnormal result does not mean that Rènü Dermatology has diagnosed you with Alzheimer’s disease.
Instead, the result provides information that you can take to your GP or specialist, who can decide whether further assessment is required.
This could include cognitive assessment, neurological review, imaging or other investigations depending on your individual circumstances.
What If My Result Does Not Suggest Alzheimer’s Pathology?
Memory and cognitive symptoms can have many different causes.
A result that does not indicate a high likelihood of Alzheimer’s pathology does not mean that persistent cognitive symptoms should be ignored.
If you or your family have noticed ongoing or worsening changes, you should still speak to your GP for appropriate assessment.
A Snapshot in Time
The LucentAD pTau217™ result reflects Alzheimer’s-related pathology at the time of testing.
If symptoms develop or change in the future, further assessment or repeat testing may be appropriate where clinically recommended.
LucentAD pTau217™ Alzheimer’s Blood Test
£479
Advanced blood-based Alzheimer’s biomarker testing
Measures p-Tau217
Simple • Non-Invasive • Specialist Laboratory Analysis
Professional in-clinic blood draw included
Results within approximately 15 working days
Available at Rènü Dermatology, Lymington
Enquire about Alzheimer’s blood testing today.
Private Alzheimer’s Blood Testing in Lymington & the New Forest
Rènü Dermatology provides access to the LucentAD pTau217™ Alzheimer’s Blood Test in Lymington, Hampshire, with professional venous blood collection carried out in clinic.
We welcome clients from Lymington, Milford on Sea, Brockenhurst, New Milton, Barton on Sea and throughout the New Forest and surrounding Hampshire area.
Frequently Asked Questions
How much is the Alzheimer’s pTau217 Blood Test?
The test costs £479 including your professional venous blood draw at Rènü Dermatology in Lymington.
What does the Alzheimer’s blood test measure?
It measures p-Tau217, a blood biomarker strongly associated with Alzheimer’s disease pathology.
Can a blood test diagnose Alzheimer’s?
The LucentAD pTau217™ test can provide important information to support Alzheimer’s assessment, but it does not replace a full clinical evaluation or medical diagnosis.
Who is the test intended for?
It may be useful for adults experiencing memory or cognitive concerns, people awaiting specialist assessment, or those looking for a non-invasive way of obtaining additional information about possible Alzheimer’s pathology.
Does the test require a lumbar puncture?
No. Only a venous blood sample is required for the LucentAD pTau217™ test.
Does it replace a PET scan?
Not necessarily. The blood test can provide valuable information without requiring imaging as part of the test itself, but a healthcare professional may still recommend imaging or other investigations depending on your result and symptoms.
How long do results take?
Results are available within approximately 15 working days after the sample reaches the laboratory.
What happens if my result is abnormal?
Your result should be discussed with your GP or an appropriate specialist. Further clinical assessment may be recommended before any diagnosis is made.
Where is my blood taken?
Your venous blood sample is professionally collected at Rènü Dermatology in Lymington and sent for specialist laboratory analysis.
